Cite
HARVARD Citation
Xu, Y. et al. (2018). Efficacy and safety comparison of nabpaclitaxel plus S-1 and gemcitabine plus S-1 as first-line chemotherapy for metastatic pancreatic cancer. Japanese journal of clinical oncology. pp. 535-541. [Online].